Manfred Lee

Chief Operating Officer @Mirvie

Adverse pregnancy outcomes such as preeclampsia, preterm birth, growth restriction, and miscarriage affect 20% of pregnancies and lead to lifelong health consequences. Additionally, maternal mortality rates continue to increase despite increased healthcare spend in the U.S. Given these unacceptable statistics, Mirvie strives to shape a new future of pregnancy health where pregnant people and their doctors understand their biological risk of APOs and can intervene before a pregnancy crisis. Mirvie enables accurate risk prediction and preventive care support with 1) its innovative RNA platform, which uses a simple blood test to reveal vital information about a pregnancy’s unique biology and detect APOs months before they occur and 2) its personalized care plans which aim to improve the utilization of and adherence to proven, preventive interventions. I lead a talented, mission-driven team that executes in the areas of product management, program management, clinical development, clinical operations, regulatory affairs, software engineering, and business development.